Sign in

CIK 0000899923

  • Accelerated filer

MYRIAD GENETICS INC

Sign in to watch
Ticker
MYGN
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
870494517
Phone
+1 801-584-3600
Business address
322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
Former names
MYRIAD GENETICS INC
  1. 4 Grant or award Chief Financial Officer acquired 60,000 shares (grant or award)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Insider Changes in Ownership
  4. 4 Grant or award Director acquired 49,796 shares (grant or award)
  5. 4 Grant or award Director acquired 49,796 shares (grant or award)
  6. 4 Grant or award Director acquired 24,148 shares (grant or award)
  7. 4 Grant or award Director acquired 49,796 shares (grant or award)
  8. 4 Grant or award Director acquired 49,796 shares (grant or award)
  9. 4 Grant or award Director acquired 49,796 shares (grant or award)
  10. 4 Grant or award Director acquired 49,796 shares (grant or award)
  11. 4 Grant or award Director acquired 49,796 shares (grant or award)
  12. 4 Grant or award President and CEO acquired 1,498 shares (grant or award)
  13. 4 Grant or award Chief Commerical Officer acquired 397,534 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Insider Changes in Ownership
  18. 4 Shares withheld for taxes Chief Scientific Officer gave up 942 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Commercial Officer gave up 1,085 shares (to pay taxes)
  20. 4 Shares withheld for taxes Chief Accounting Officer gave up 362 shares (to pay taxes)

Page 4 of 65 · 1,293 filings